PlasCred Circular Innovations Inc. Announces Stock Option Grant

Rhea-AI Summary

PlasCred Circular Innovations (MGPRF) granted 1,000,000 stock options to its directors at $0.14 per common share, exercisable for 5 years. Options vest one-third immediately, one-third at six months, and one-third at twelve months from the grant date.

News Market Reaction – MGPRF

+16.06%

1 alert

+16.06% News Effect

On the day this news was published, MGPRF gained 16.06%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Calgary, Alberta--(Newsfile Corp. - January 29, 2026) - PlasCred Circular Innovations Inc. (CSE: PLAS) (FSE: XV2) (the "Company" or "PlasCred"), announces a grant of stock options. The Company has granted an aggregate of 1,000,000 stock options to its directors at a price of $0.14 per common share for a period of 5 years from grant, pursuant to its Stock Option Plan. The stock options vest one-third immediately; one-third in six months; and one-third twelve months from date of grant.

About PlasCred Circular Innovations Inc.

PlasCred is an Alberta-based company developing an advanced plastic recycling facility. The Company's engineered, modular platform converts mixed plastic waste into refined hydrocarbon condensate for use in virgin plastic production, petrochemical feedstock, and upstream energy applications.

For further information on PlasCred, visit our website at www.PlasCred.com

ON BEHALF OF THE BOARD
Troy Lupul - President & CEO

Contact Information
For more information please contact:

PlasCred Circular Innovations Inc.
Investor Relations
Email: IR@PlasCred.com

Forward-Looking Statements

Forward-looking statements in this release include, but are not limited to: the timing, scope, and cost of constructing the Neos facility; projected operating performance, revenues, EBITDA, internal rate of return, and payback period; anticipated greenhouse-gas reductions; the availability, terms, and timing of financing; feedstock sourcing, quality, and pricing; regulatory approvals; offtake performance; and the Company's broader commercialization, replication, and expansion plans, including the proposed Maximus facility and any future North American locations. Forward-looking statements are based on management's current assumptions and expectations, which are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. Such risks and uncertainties include, without limitation: construction, commissioning, and start-up risks; cost overruns; delays or disruptions in the supply chain; ability to achieve and maintain nameplate capacity at scale; changes in feedstock availability, composition, or pricing; fluctuations in commodity prices and foreign exchange rates; failure of counterparties to perform under offtake, financing, or strategic agreements; changes in applicable laws, regulations, or EPR requirements; inability to secure or maintain permits; adverse changes in market demand for advanced recycling products; evolving ESG reporting standards; technology performance or reliability issues; and general economic, political, and capital market conditions. A discussion of these and other factors that may affect future results is contained in the Company's continuous disclosure filings available under its profile on SEDAR+ at www.sedarplus.ca. Forward-looking statements are not guarantees of future performance, and readers should not place undue reliance on them. Except as required by applicable securities laws, the Company undertakes no obligation to revise or update any forward-looking statements to reflect new events, circumstances, or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282020

FAQ

What stock option grant did PlasCred (MGPRF) announce on January 29, 2026?

PlasCred granted 1,000,000 stock options to directors at $0.14 per share, exercisable for five years. According to the company, options vest one-third immediately, one-third after six months, and one-third after twelve months from the grant date.

How do the PlasCred (MGPRF) options vest and when can directors exercise them?

The options vest in three tranches: one-third immediately, one-third at six months, and one-third at twelve months. According to the company, each option is exercisable at $0.14 per share for a period of five years from the grant.

Will the PlasCred (MGPRF) option grant dilute existing shareholders?

The grant creates potential dilution if all options are exercised at $0.14 per share over five years. According to the company, 1,000,000 options were issued to directors, which could increase outstanding shares if exercised.

What is the exercise price and term for PlasCred (MGPRF) director options granted January 29, 2026?

The exercise price is $0.14 per common share and the term is five years from the grant date. According to the company, the options follow its Stock Option Plan and include the specified vesting schedule.

Where can shareholders find details on PlasCred's (MGPRF) stock option plan and grants?

Shareholders can review the company’s Stock Option Plan and grant disclosures in corporate filings or investor materials. According to the company, the grant was made pursuant to its existing Stock Option Plan and includes standard vesting and term details.